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RESEARCH ARTICLE
RELATIONSHIP BETWEEN CELIAC DISEASE AND REFRACTORY 
IDIOPATHIC EPILEPSY  IN CHILDREN
Abstract
Objective
Epilepsy occurs with a yearly incidence of 40 per 100,000 children, of which 
more than 25% are resistant to drug therapy. Epilepsy may occur in autoimmune 
diseases like lupus, celiac disease and myasthenia gravis. In this study, the 
relationship between celiac disease and refractory epilepsy was evaluated in 
children with idiopathic epilepsy.
Material & Methods
Hundred-fifty-five children (mean age, 6.7±3.3 years) with idiopathic and 
cryptogenic epilepsy referred to the neurology clinic were studied in two groups; 
drug controlled epilepsy (control, 82 patients) and refractory epilepsy groups 
(case, 73 patients). Both groups underwent serological tissue transglutaminase 
antibody measurement by ELISA. In seropositive cases, small intestine biopsy 
was conducted. Data analysis was performed using  student’s t test and 2 test.
cooperate for biopsy.
Conclusion
If the relationship between celiac disease and epilepsy, especially in cases 
of symptomatic or oligosymptomatic celiac is proved, using gluten free 
diet increases the ability to control epilepsy particularly in refractory cases. 
We suggest celiac disease survey is not required in patients with idiopathic 
epilepsy.
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Introduction
Epilepsy with the incidence of 40 per 100,000 children in year happens, which more 
than 25% of the cases are resistant to drug therapy (1). In many cases the cause 
of seizure is not detectable in brain function (idiopathic-cryptogenic epilepsy) 
(1). Epilepsy has several causes and can occur in autoimmune diseases such as 
lupus, celiac disease and myasthenia Gravis (1-3). Celiac disease, a relatively 
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Seven (0.04%) patients had celiac disease based on a positive tissue 
transglutaminase antibody and three patients (0.01%) based on a positive biopsy. Two 
patients (2.4%) with drug controlled epilepsy (control group) and five  with 
refractory  epilepsy  (case  group)  had  seropositive  celiac  disease  (p=0.255).  In  the 
biopsy survey of six seropositive patients, one patient (1.2%) in the drug controlled 
epilepsy and two patients (2.7%) in the refractory epilepsy group had positive biopsy 
for celiac disease (p = 0.604). One seropositive patient did not 
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common autoimmune malabsorption disorder due to a 
permanent intolerance to gluten and a 1% prevalence, 
of which 3.5 to 7.5% have seizure attacks (1). 
The relationship between epilepsy and celiac disease 
has been discussed in several studies (2,4). Studies 
for assessment of the effects of gluten free diet on the 
control of idiopathic epilepsy are still not enough, but 
preliminary studies show if this treatment regimen is 
started early, it is possible to significantly improve 
seizure control (5-8). On the other hand, because there 
is no effective treatment for refractory epilepsy, a 
combined therapy with antiepileptic drugs and a gluten-
free diet is very promising (2,4), which may also can be 
used in the early diagnosis of this disease (4). 
As other studies have evaluated the relationship 
between epilepsy and celiac disease in the adults 
group, in this study, this relationship has been assessed 
between celiac disease and epilepsy in children who 
were suffering from idiopathic epilepsy.
Material & Methods
In this case-control study, the assessed population 
included 1 to 16-year-old children with idiopathic-
cryptogenic epilepsy referred to the pediatric neurology 
clinic of Mofid university-affiliated hospital of Tehran 
(Iran) from 2009-2010. Then 155 referred epileptic 
patients who had the inclusion criteria were studied. 
The inclusion criteria were:
1. Detection of epilepsy based on the International 
Association of Epilepsy criteria.
2. History of convulsions at least two non-provoked at 
least a month away. Patients with idiopathic-cryptogenic 
epilepsy and or epilepsy associated with stroke.
3.Age between 1-16 years. 
4.Seizure onset after the age of 6 months.
In addition, patients with the following conditions were 
excluded: known etiology for epilepsy or symptomatic 
epileptic patients, neonatal seizures, seizures beginning 
before the age of 6 months.
Initially a full history of the patients were taken and in 
case of having the inclusion criteria, the demographic 
data of the patients including age, gender and the clinical 
characteristics of epilepsy including the seizure type, 
clinical findings, findings of electroenchaphalography 
(EEG) and brain CT-scan and response to medical 
therapy were recorded in the information forms.
In this study, according to the limited studies for the 
evaluation of the association between celiac disease 
and epilepsy, 155 patients were studied. we devided 
these patients in two groups.
Control group:82 patients with controlled epilepsy 
and cases: 73 patients with uncontrolled or refractory 
epilepsy.
Children continue to have seizure after at least more than 
2 standard antiepileptic drugs and one new antiepileptic 
drug considered as refractory epilepsy groups. 
Both control (drug controlled epilepsy group) and 
refractory epilepsy groups (73 patients) underwent the 
serological study of tissue transglutaminase antibody 
measurement by ELISA method. All samples were 
tested with standard kits manufactured in Wendeisheim 
(Germany) and titers above headline 20 IU were 
considered positive. In seropositive cases, a small 
intestine biopsy was conducted by an expert pediatric 
gastroenterologist. All the biopsy samples were studied 
by a pediatric pathologist who had no known serological 
results (single blinding). Subsequently, data analysis 
was performed using statistical software SPSS (version 
17) and t student’s test and χ 2 test. Also, to determine 
the correlation between quantitative variables Pearson 
correlation coefficients were used. P values less than 
0.05 were considered statistically significant 
Results
In this study, 155 children with idiopathic-cryptogenic 
epilepsy were studied. In the refractory epilepsy group 
(case), 47 patients (64.4%) were male and 26 patients 
(35.6%) were female, and in the drug controlled epilepsy 
group (control), 49 patients (60.5%) were male and 32 
patients (39.5%) were female. Statistically significant 
differences between gender groups in the two studied 
groups were not observed (p=0.619).
The mean age of the refractory epilepsy patients was 
7.6±3.1 years and for the drug controlled epilepsy 
group this number was 5.9±3.6 years which showed 
no significant difference between the two groups (P= 
0.002) (Fig1). In refractory epileptic patients, the mean 
age onset of seizure was 2.8±2.3 years which was 
4.6±3.3 years in the drug controlled epilepsy group 
demonstrating no significant difference between the 
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two groups (p=0.001).
In the refractory epilepsy group, 29 patients had 
idiopathic epilepsy (39.7%) and 44 patients had 
cryptogenic epilepsy (60.3%); in the drug controlled 
epilepsy group 63 patients had idiopathic epilepsy 
(77.8%) and 18 patients had cryptogenic epilepsy 
(22.9%). There was no significant differences between 
the types of epilepsy in the two groups (p=0.052). 
Regarding neurological development status in the 
refractory epilepsy group, 30 patients (41.1%) had a 
normal state and 43 patients (58.9%) had an abnormal 
state which was 64 patients (79%) and 17 patients 
(21%), respectively for the drug controlled epilepsy 
group. Statistically significant differences were 
observed between the evolution of neurological status 
in the two groups under investigation (p=0.06).
After the serologic test (anti transglutaminase 
antibody), two patients (2.4%) in the drug controlled 
epilepsy group and five patients (6.8%) in the refractory 
epilepsy group were seropositive, of course there was 
no significant difference between the two groups 
(p=0.255) (Table 1).
All patients with positive serology were called for 
endoscopy and biopsy, except one patient because 
of the wrong telephone number, communication 
was not feasible. After arrangement with an expert 
pediatric gastroenterologist and pathologist, biopsy 
samples were taken from six patients with seropositive 
celiac disease and were sent to the laboratory. In the 
pathologic examination, one patient (1.2%) in the drug 
controlled epilepsy group and two patients (2.7%) in 
the refractory epilepsy group were positive for celiac 
disease. Statistically, no significant differences were 
observed between positive biopsy results for celiac 
disease between the refractory epilepsy group and the 
drug controlled epilepsy group (p=0.604) (Table 2).
It should be mentioned that during the follow-up of 
patients in our study, a seven-year-old girl with epilepsy 
resistant to treatment, seropositive celiac disease and 
positive biopsy for disease, was treated and controlled 
with combined therapy including celiac diet (gluten-
free) and anti-epileptic drugs of which the celiac diet 
healed her evolutionary criteria.
 
 Figure 1. Mean age distribution in the drug 
controlled epilepsy group (control) and refractory 
epilepsy group (case)
Table 1: Serologic results for celiac disease in the 
drug controlled epilepsy group (control) and the 





73 (47.4%)5 (6.8%)68 (93.2%)
 Refractory
epilepsy
82 (52.6%)2 (2.4%)80 (97.6%)
 Drug controlled
epilepsy
155 (100%)7 (3.9%)148 (96.1%)total
Table 2:Pathologic results for celiac disease in the 
drug controlled epilepsy group (control) and the 





73 (47.4%)2 (2.7%)71 (97.3%)
 Refractory
epilepsy
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Discussion
Celiac disease is an autoimmune disease with the 
involvement of the gastrointestinal tract, but its spectrum 
of clinical symptoms is broad and contains various 
organs including the peripheral and central nervous 
system (2). The etiology of neurological complications 
in celiac disease is unknown. But recently many 
neurological complications including seizures in these 
patients have been reported (2).
The relationship between celiac and epilepsy is not 
definite yet, but many studies suggest this relationship 
particularly symptomatic and oligosymptomatic types 
of celiac (1,2,4). Neurological symptoms such as 
learning disorders, ADHD, headache, and cerebellar 
ataxia in children with celiac have been reported (1,3,7). 
Neuropathy, sensory ataxia, weakness and decline of 
DTR, distal axonopathy and stroke are seen in adult 
patients (1,3). Refractory epilepsy that is commonly 
associated with calcification in the occipital lobe and 
white matter brain lesions similar to MS have also been 
reported worldwide (1,3,8-11). Several studies have 
reported neurological symptoms among celiac patients 
even in cases that have been on a gluten free diet. These 
symptoms include:
1. Epilepsy, especially with partial complex seizures 
(1,2,4,12)
2. Ataxia (7,8); celiac has been mentioned as the most 




5. Peripheral neuropathy (1,6)
6. White matter lesions in the brain (1,8)
In a study in 2004 that was performed in Turkey to assess 
the relationship between celiac disease and epilepsy on 
77 children with idiopathic-cryptogenic epilepsy (51.9% 
of the subjects had generalized epilepsy and 48.1% of 
them had the partial type), 12 patients (15.6%) (2 male) 
were positive for tissue transglutaminase antibodies. 
Due to the lack of cooperation of the children’s parents, 
only seven children had been biopsied of which all 
(100%) had grade three enteropathy (14). 
In Iran, the prevalence of celiac disease in the general 
population especially children and epileptic patients 
has not been a comprehensive assay. In our study, of 
155 studied epileptic children, seven patients (0.04%) 
had a positive serology; among which patients with 
seropositivity one patient was excluded from the study 
due to lack of cooperation, three patients (50%) had 
positive biopsy results for celiac enteropathy. One of 
the cases was in the drug controlled epilepsy group 
(control), two cases were in the refractory epilepsy 
group, despite more positive biopsy results in cases 
of the refractory epilepsy group, based on statistical 
analysis, no significant difference was observed 
between the two groups.
In a case control study conducted in Ireland (1998) 
to investigate the prevalence of celiac in epileptic 
patients, 177 patients with epilepsy (age 14-80 years) 
were studied for IgA antiendomesial antibody which 
were then compared with the control group. In this 
study, celiac frequency in the idiopathic epileptic 
group had been reported as one person per 37 patients 
which indicates a significant relationship between 
these two diseases. Of four seropositive patients, all 
of them showed typical pathology of celiac disease in 
the intestinal biopsy. Although in this study the control 
group were not matched for age and sex with the 
epileptic group, it was able to show strong evidence 
that epilepsy occurs with more frequency than the 
general population in celiac patients (2). 
In the second part of this study, 16 patients (six males, 
10 females) who had celiac and epilepsy were evaluated 
for seizures and neuroradiologic findings that showed 
a specific syndrome including celiac disease, epileptic 
seizure and brain calcification (2). Further reports of this 
syndrome were reported in Italian centers (2). It should 
be mentioned that in our study in the neuroradiology 
findings, three patients with positive celiac biopsy had 
no evidence of this syndrome.
In another study conducted in 2004 in Turkey, 1263 
children were studied for celiac disease. The prevalence 
of celiac disease was 0.87% based on seropositivity tissue 
transglutaminase antibody and 1.1% based on biopsy 
results. In addition, in epileptic patients seropositivity 
was 15.6% and positive biopsy for celiac disease was 
9.1%; these findings point out that celiac disease is more 
common in epileptic children. In this study, contrary to 
the results of our study, the association between celiac 
disease and epilepsy had been approved and therefore, 
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the researchers recommended the evaluation of celiac 
disease in epileptic children (15).
In 2007, a similar study was conducted in Greece and 
255 children with idiopathic epilepsy were assessed 
for anti-gliadin antibody, tissue transglutaminase 
antibody and antiendomesial antibody and 
antireticulin antibody and were then compared with 
280 healthy children. In this study, a significant 
difference for the prevalence of celiac disease had 
been reported between the two groups (12). In a 
study in Ankara, Turkey on 70 children, there was 
a similar report (16), in which both studies suggest 
that children with idiopathic-cryptogenic epilepsy 
should be screened for celiac disease (12,16).
In our study, the prevalence of celiac disease in 
epileptic patients based on seropositive antibody 
tissue transglutaminase was 0.04% and by positive 
biopsy was 0.01%, in which the prevalence of celiac 
disease was much less than similar studies (14,15); 
in addition, a significant relationship between 
epilepsy and celiac disease was not observed. Of 
course, perhaps this discrepancy is because we 
examined idiopathic-cryptogenic cases, while in 
similar studies in Turkey only idiopathic epilepsy 
has been investigated (14,15). 
However, in two similar studies in 2005 (Ranua et 
al.) and 2009 (Giordano et al. in Italy) no significant 
difference was noted in the prevalence of celiac 
disease between epileptic patients and healthy 
children (17,18). In a study by Luostarinem and 
colleagues in 2001 on 199 patients with epilepsy 
celiac disease was proved only in five children 
(0.02%) (19), indicating that the prevalence of 
celiac disease in these epileptic patients was similar 
with our study results.
Yet, studies on the effect of gluten-free diet for 
controlling seizure are not enough; some studies show 
that if this regime is started early, dramatic improvement 
will encounter in the patients’ seizure status (20). On 
the other hand, neurologic complications, especially 
uncontrolled epilepsy and brain calcification occur only 
in patients who are not on the gluten-free diet (1). Clear 
remission in gluten ataxia has been reported in cases 
on very precise gluten-free diet (21). Italian researchers 
have stated that patients with untreated celiac suffered 
from hypoperfusion of at least one area of the brain due 
to vascular injury (22) this problem has been reported 
especially in the syndrome with calcification of the 
occipital lobe of the brain and epilepsy, and in one 
patient it was noted as cortical vascular anomaly (23). 
In conclusion, If symptomatic celiac disease is 
considered as the etiology for refractory epilepsy using 
gluten-free diet increases the ability to control epilepsy, 
particularly in refractory cases (1,8,13,20).
Finally, according to study results in our center, we 
may suggest that in patients with idiopathic epilepsy, 
a celiac disease survey is not required. Despite this 
result, we recommend a broad study in different regions 
of Iran to compare the prevalence of celiac disease 
and the related factors on the general population and 
epileptic patients.
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